Zevra Therapeutics announced that it has become a Corporate Council member of the National Organization for Rare Disorders and reiterated its commitment to the rare disease community by celebrating Rare Disease Day 2023.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on KMPH:
- Zevra Therapeutics Begins Trading as ZVRA
- Zevra Therapeutics, a Rare Disease Therapeutics Company, Files Preliminary Proxy
- Zevra Therapeutics to Report Fourth Quarter and Full-Year 2022 Results
- Zevra announces arimoclomol featured in two poster presentations
- Zevra Therapeutics Announces Arimoclomol Research Featured in Two Poster Presentations at the 19th Annual WORLDSymposium™ 2023